Bambino Gesù Children's Hospital at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Bambino Gesù Children's Hospital brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on engineered immune cells for childhood cancer. Topics include IL-15 to improve the fitness and persistence of GD2-directed CAR T cells in neuroblastoma and NK cells built to target PD-L1 and HLA-E at once.

OrganizationESGCT 2026 Attendance
Poster
Thu Oct 29
2:00pm–4:00pm
IL-15 enhances fitness and persistence of CAR.GD2 T-cells in high tumor burden neuroblastoma
Immunotherapy and CAR T cells
Poster
Thu Oct 29
2:00pm–4:00pm
Multifunctional engineered NK cells overcome tumor immunosuppression by combining PD-L1 and HLA-E targeting and endogenous IL15 production.
Immunotherapy and CAR T cells

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bambino Gesù Children's Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction